Heres how the value chain of Pharmaceutical players look like - Intermediates API (Generic/Specialty) Formulations (Domestic/ROW/USA) Patient Then there are these CDMO players who serves innovator pharma companies NCE/Innovation drug discovery, biosimilars, novel biologics and then Domestic Branded India prescription-driven, doctor-detailing led businesses So with this background lets get on and dive deeper on the themes in this space that have performed strongly and the tailwinds that are there in each of the themes 1) Aarti Drugs - The Aarti Drugs story over the last three years can be summed up in this single chart The company has delivered consistent positive volume growth every single year for the last 5 years: 5%, 11%, 10%, 7% respectively from FY22 to FY26
TODAY Study Group, Bjornstad P, Drews KL et al (2021) Long-term complications in youth-onset type 2 diabetes
GLP-Squared Injection is $289/mo month-to-month (or $249/mo on the 3-month plan), with pricing flat across all dose levels
Setting Realistic Expectations for Results PT-141, also known as bremelanotide, is designed to work with your brain to enhance sexual desire
Development of multifunctional molecules as potential therapeutic candidates for Alzheimers disease, Parkinsons disease, and amyotrophic lateral sclerosis in the last decade
